eMeasure Title Fibrinolytic Therapy Received Within 30 Minutes of Hospital Arrival
eMeasure Identifier
(Measure Authoring Tool)
60 eMeasure Version number 3
NQF Number 0164 GUID 909cf4b4-7a85-4abf-a1c7-cb597ed1c0b6
Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward Oklahoma Foundation for Medical Quality
Measure Developer Oklahoma Foundation for Medical Quality
Endorsed By National Quality Forum
Description
Acute myocardial infarction (AMI) patients with ST-segment elevation on the ECG closest to arrival time receiving fibrinolytic therapy during the hospital stay and having a time from hospital arrival to fibrinolysis of 30 minutes or less.
Copyright
Measure specifications are in the Public Domain.

LOINC (R) is a registered trademark of the Regenstrief Institute.

This material contains SNOMED Clinical Terms (R) (SNOMED CT(c)) copyright 2004-2010 International Health Terminology Standards Development Organization. All rights reserved.
Disclaimer
None
Measure Scoring Proportion
Measure Type Process
Stratification
None
Risk Adjustment
None
Rate Aggregation
None
Rationale
Time to fibrinolytic therapy is a strong predictor of outcome in patients with an acute myocardial infarction. Nearly 2 lives per 1000 patients are lost per hour of delay (Fibrinolytic Therapy Trialists' Collaborative Group, 1994). National guidelines recommend that fibrinolytic therapy be given within 30 minutes of hospital arrival in patients with ST-elevation myocardial infarction (O'Gara, 2013).
Clinical Recommendation Statement
National guidelines recommend that fibrinolytic therapy be given within 30 minutes of hospital arrival in patients with ST-elevation myocardial infarction.
Improvement Notation
Higher score indicates better quality
Reference
Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). 2004.
Reference
Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet. 1994;343:311-22.
Reference
Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non–ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non–ST-Elevation Myocardial Infarction). J Am Coll Cardiol. 2008;52:2046–99.
Reference
O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:485–510.
Definition
None
Guidance
Because of QDM limitations to identify the closest event to another event, the denominator will identify the last ECG performed within 1 hour prior to hospital arrival OR the first ECG performed after hospital arrival.

Denominator element guidance: 

For the denominator data element "Diagnostic Study, Result: Hospital Measures-ECG Impression," EHR implementations will need to develop mechanisms to capture ECG findings to support denominator criteria for this measure. The measure specification indicates allowable findings. The source of the ECG results should be a physician/APN/PA (rather than the ECG machine's computerized results).

Numerator element guidance:

This measure expects fibrinolytic therapy within 30 minutes of hospital arrival. Those patients receiving fibrinolysis greater than 30 minutes after arrival may be excluded from the denominator only if there is a documented reason for a delay or documented occurrence of intubation, cardiopulmonary arrest or mechanical circulatory assist device placement within the first 30 minutes after arrival. Patients receiving fibrinolysis greater than 30 minutes after arrival and with no reason provided are not compliant with the numerator criteria and will remain in the denominator.

Exclusion element guidance: 

The intent for the exclusion for patients who are clinical trial participants was to be limited to patients participating in a clinical trial for acute myocardial infarction (AMI), ST elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI), heart attack, or acute coronary syndrome (ACS), the same conditions as covered by the measure. However, the value set specifying clinical trial participation is not limited to a specific type of trial. 

Transfers from another hospital are excluded since care may have been delivered in the other setting. Transfers from those hospitals are considered exclusions regardless of whether the receiving hospital has the same or different hospital unique identifier as the transferring hospital.

Exception element guidance: 
Medical or patient reasons for not performing a procedure or giving a medication are categories for valid medical or patient reasons that are not specifically listed in the exclusion section of the measure. Each is expected to be captured and made available for measurement or clinical decision support within the EHR workflow but the exact method or location of capture is a local or vendor decision.

Denominator, Numerator, Exclusion and Exception element guidance:
The criteria indicate scenarios in which the patient is admitted to the hospital directly or the patient is admitted from the Emergency Department (ED). The calculation is to indicate the timing from arrival at the facility to the occurrence of an event.
Transmission Format
None
Initial Patient Population
All hospital discharges for acute myocardial infarction (AMI) with hospital stays <= 120 days during the measurement year for patients age 18 and older at the time of hospital admission with ST-elevation on electrocardiogram (ECG) who received fibrinolytic therapy.
Denominator
Patients age 18 and older with an ICD-9-CM Principal Diagnosis Code for AMI AND ST-segment elevation on the last ECG performed prior to hospital arrival or the first ECG performed after hospital arrival; AND Fibrinolytic therapy received within 6 hours after hospital arrival AND Fibrinolytic therapy is primary reperfusion therapy.
Denominator Exclusions
Patients enrolled in clinical trials.
Patients received as a transfer from an inpatient or outpatient department of another hospital. 
Patients received as a transfer from the emergency/observation department of another hospital. 
Patients received as a transfer from an ambulatory surgery center.
Numerator
AMI patients whose time from hospital arrival to fibrinolysis is 30 minutes or less.
Numerator Exclusions
Not Applicable
Denominator Exceptions
Patients who did not receive fibrinolytic therapy within 30 minutes and had a documented reason for delay in fibrinolytic therapy.
Measure Population
Not Applicable
Measure Observations
Not Applicable
Supplemental Data Elements
For every patient evaluated by this measure also identify payer, race, ethnicity and sex.

Table of Contents


Population criteria

Data criteria (QDM Data Elements)

Reporting Stratification

Supplemental Data Elements




Measure Set
Acute Myocardial Infarction (AMI)